Table 2 a. Association with overall survival and clinicopathologic characteristic in LIHC patients using univariate cox regression. b. Multivariate survival analysis using cox regression.
Clinical characteristics | p-value | HR (95%CI) | Lower | Upper |
|---|---|---|---|---|
a | ||||
Age (≥ 60 vs < 60) | 0.219 | 0.79 (0.54–1.15) | 0.54 | 1.15 |
Gender (male vs female) | 0.278 | 1.23 (0.85–1.79) | 0.85 | 1.79 |
TNM stage (II vs. I) | 0.158 | 1.43 (0.87–2.36) | 0.87 | 2.36 |
TNM stage (III vs. I) | 0.00E+00 | 2.78 (1.81–4.26) | 1.81 | 4.26 |
TNM stage (IV vs. I) | 0.004 | 5.54 (1.71–17.96) | 1.71 | 17.96 |
Histologic grade (G2 vs. G1) | 0.636 | 1.15 (0.64–2.08) | 0.64 | 2.08 |
Histologic grade (G3 vs. G1) | 0.496 | 1.24 (0.67–2.28) | 0.67 | 2.28 |
Histologic grade (G4 vs. G1) | 0.301 | 1.72 (0.62–4.80) | 0.62 | 4.80 |
HAUS5 (high vs low) | 0.033 | 1.50 (1.03–2.12) | 1.03 | 2.12 |
b | ||||
Age (≥ 60 vs < 60) | 0.315 | 1.22 (0.83–1.79) | 0.83 | 1.79 |
Gender (male vs female) | 0.64 | 0.91 (0.61–1.35) | 0.61 | 1.35 |
TNM stage (II vs. I) | 0.236 | 1.35 (0.82–2.24) | 0.82 | 2.24 |
TNM stage (III vs. I) | 0.00E+00 | 2.69 (1.75–4.13) | 1.75 | 4.13 |
TNM stage (IV vs. I) | 0.004 | 5.97 (1.76–20.19) | 1.76 | 20.19 |
HAUS5 (high vs low) | 0.033 | 1.52 (1.03–2.23) | 1.03 | 2.23 |
